Evidence of macrophage and lymphocyte, but not dendritic cell, infiltration in posterior uveal melanomas, whilst cultured uveal melanomas demonstrate pluripotency by expressing CD68 and CD163

被引:13
作者
Woodward, J [1 ]
Sisley, K [1 ]
Reeves, G [1 ]
Nichols, C [1 ]
Parsons, MA [1 ]
Mudhar, H [1 ]
Rennie, I [1 ]
机构
[1] Univ Sheffield, Royal Hallamshire Hosp, Div Clin Sci S, Acad Unit Ophthalmol & Orthopt, Sheffield S10 2JF, S Yorkshire, England
关键词
dendritic cell; immunohistochemistry; leucocyte; macrophage; uveal melanoma;
D O I
10.1111/j.0959-9673.2004.00370.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Although variation in the level of macrophage infiltration has been reported in uveal melanoma, little is known about the expression of other leucocyte markers. An immuno- histochemistry study of the levels of expression of macrophage and other leucocyte markers, in a series of 10 primary choroidal melanoma biopsies, was undertaken. Biopsies were either fixed immediately in formalin and embedded in paraffin wax or established as short-term cultures. Using single- and double-labelling immunohistochemistry, cultured cells and paraffin sections were analysed for a range of melanoma (HMB45, Melan A, S100 and tyrosinase) and immune cell (CD68, CD163, CD45 and CD1a) markers. All samples expressed at least two known melanoma markers. Infiltrating macrophages were present in the majority of sections. When cultured specimens were studied by double-labelling immunofluorescence, uveal melanoma cells were seen to express macrophage markers or have cross-reactivity with related proteins. Expression of the leucocyte antigen CD45 was observed in three tumours but was not present in any cultured cells, whilst the expression of the dendritic cell marker CD1a was absent from all samples.
引用
收藏
页码:35 / 43
页数:9
相关论文
共 28 条
  • [1] Albert DM, 1998, AM J OPHTHALMOL, V125, P745
  • [2] Expression of Fas and Fas ligand in uveal melanoma: biological implication and prognostic value
    Anastassiou, G
    Coupland, SE
    Stang, A
    Boeloeni, R
    Schilling, H
    Bornfeld, N
    [J]. JOURNAL OF PATHOLOGY, 2001, 194 (04) : 466 - 472
  • [3] BER-MAC3 - NEW MONOCLONAL-ANTIBODY THAT DEFINES HUMAN MONOCYTE MACROPHAGE DIFFERENTIATION ANTIGEN
    BACKE, E
    SCHWARTING, R
    GERDES, J
    ERNST, M
    STEIN, H
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1991, 44 (11) : 936 - 945
  • [4] Expression of integrins, degradative enzymes and their inhibitors in uveal melanoma:: differences between in vitro and in vivo expression
    Baker, JKL
    Elshaw, SR
    Mathewman, GEL
    Nichols, CE
    Murray, AK
    Parsons, MA
    Rennie, IG
    Sisley, K
    [J]. MELANOMA RESEARCH, 2001, 11 (03) : 265 - 273
  • [5] Spontaneously formed tumorigenic hybrids of Meth A sarcoma and macrophages grow faster and are better vascularized than the parental tumor
    Busund, LTR
    Killie, MK
    Bartnes, K
    Seljelid, R
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 100 (04) : 407 - 413
  • [6] Chen X, 2002, INVEST OPHTH VIS SCI, V43, P2533
  • [7] EMAP-II expression is associated with macrophage accumulation in primary uveal melanoma
    Clarijs, R
    Schalkwijk, L
    Ruiter, DJ
    de Waal, RMW
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (05) : 1801 - 1806
  • [8] Inflammation and cancer
    Coussens, LM
    Werb, Z
    [J]. NATURE, 2002, 420 (6917) : 860 - 867
  • [9] HLA expression and tumor-infiltrating immune cells in uveal melanoma
    deWaardSiebinga, I
    Hilders, CGJM
    Hansen, BE
    vanDelft, JL
    Jager, MJ
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1996, 234 (01) : 34 - 42
  • [10] KP1 (CD 68) STAINING OF MALIGNANT MELANOMAS
    FACCHETTI, F
    BERTALOT, G
    GRIGOLATO, PG
    [J]. HISTOPATHOLOGY, 1991, 19 (02) : 141 - 145